Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma

Xingming Zhang1,2, Xiaoxue Yin3, Haoran Zhang1,2

  • 1Department of Urology, West China Hospital, Sichuan University, No. 37 Guoxue Xiang, Chengdu, 610041, Sichuan, China.

BMC Cancer
|January 12, 2019
PubMed
Abstract

Insights

Differential expression of T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) was observed between primary and metastatic renal cell carcinoma (RCC). TIM-3 expression in metastatic sites provides more accurate prognostic information for patients with RCC.

Area of Science:

  • Oncology
  • Immunology
  • Pathology

Background:

  • Renal cell carcinoma (RCC) exhibits significant heterogeneity, potentially leading to differential immune checkpoint expression between primary and metastatic tumors.
  • Evaluating T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) expression differences is crucial for understanding RCC progression and treatment response.

Purpose of the Study:

  • To investigate the differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma.
  • To assess the prognostic value of TIM-3 expression in both primary and metastatic RCC.

Main Methods:

  • Retrospective analysis of 163 RCC cases with metastases resected or biopsied.
  • Immunohistochemical assessment of TIM-3 expression.
  • Statistical analysis using SPSS, GraphPad Prism, and R software.

Main Results:

  • TIM-3 was detected in 56.4% of cases, with a numerically higher rate in primary tumors (53.0%) than in metastases (42.6%).
  • A statistically significant difference in TIM-3 expression was found between primary and metastatic sites (p=0.002), with poor concordance (Kappa=0.331).
  • TIM-3 expression in both primary and metastatic tumors was associated with longer progression-free survival (PFS) and overall survival (OS), and improved predictive accuracy for survival models.

Conclusions:

  • Significant differences in TIM-3 expression exist between primary and metastatic RCC.
  • Analysis of metastatic sites may offer more accurate biological information for clinical decision-making and prognosis.
  • The role of TIM-3 in RCC warrants further investigation due to controversial findings.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Conserved Binding Sites01:49

Conserved Binding Sites

1.9K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.5K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.0K
Ligand Binding Sites02:40

Ligand Binding Sites

8.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.1K